Response to 'Pervasive Sequence Patents Cover the Entire Human Genome'
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Shine Tu, et al., Response to 'Pervasive Sequence Patents Cover the Entire Human Genome', 6 Genome Med. 14 (2014).
Institutional Repository Citation
Tu, Shine and Heled, Yaniv, "Response to 'Pervasive Sequence Patents Cover the Entire Human Genome'" (2014). Faculty Publications By Year. 1213.
This document is currently not available here.